Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)

Fig. 2

Kaplan–Meier survival curves showing the relationship between loss of response (A) and colectomy (B) according to anti-TNF therapy. Loss of response was lower in the Infliximab compared to the Adalimumab group (p = 0.001). There was no difference regarding colectomy rates between the groups (p = 0.651)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us